Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Seattle Biomedical Research Institute

Seattle Biomedical Research Institute is the largest independent, non-profit organization in the United States focused solely on infectious disease research. The mission of SBRI's nearly 200 employees is to eliminate the world's most devastating infectious diseases through leadership in scientific discovery.Founded in 1976, SBRI's research targets the world's most underserved populations: the 14 million people who die each year from diseases such as malaria, HIV/AIDS and tuberculosis as well as other lesser known, but equally deadly diseases, including African sleeping sickness, Chagas disease and leishmaniasis. SBRI's discoveries are the basis for new diagnostics, drugs and vaccines that provide long-term solutions to the world's biggest health problems.


Contact Details:
307 Westlake Avenue N, Suite 500
Seattle
Washington
98109-5219
United States of America
Tel:(206) 256-7200
Fax:(206) 256-7229
Email:info@sbri.org
WWW:

www.sbri.org/




Loading...

Recent Publications by Seattle Biomedical Research Institute:

Interactions Between Lipids And Human Anti-HIV Antibody 4E10 Can Be Reduced Without Ablating Neutralizing Activity.
Human 4E10 is one of the broadest-specificity, HIV-1 neutralizing,...
13th November, 2009
Division of Basic Sciences, Fred Hutchinson Cancer Research Center, J Virol. 2009 Nov 11.
DOI Direct Link
Organization and evolutionary trajectory of the mating type (MAT) locus in the dermatophyte and dimorphic fungal pathogens.
Sexual reproduction in fungi is governed by a specialized genomic region,...
3rd November, 2009
Department of Molecular Genetics and Microbiology, Duke University Medical Eukaryot Cell. 2009 Oct 30.
DOI Direct Link
Improving the expression of recombinant soluble HIV Envelope glycoproteins using pseudo-stable transient transfection.
The Envelope glycoprotein (Env) of the human immunodeficiency virus (HIV)...
28th October, 2009
Seattle Biomedical Research Institute, Seattle, WA 98109, United States. Vaccine. 2009 Oct 24.
DOI Direct Link
TriTrypDB: a functional genomic resource for the Trypanosomatidae.
TriTrypDB (http://tritrypdb.org) is an integrated database providing...
22nd October, 2009
Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Nucleic Acids Res. 2009 Oct 20.
DOI Direct Link
Widespread variation in transcript abundance within and across developmental stages of Trypanosoma brucei.
BACKGROUND: Trypanosoma brucei, the causative agent of African sleeping...
21st October, 2009
Seattle Biomedical Research Institute, 307 Westlake Ave. North, Seattle, BMC Genomics. 2009 Oct 19;10:482.
DOI Direct Link

View more Seattle Biomedical Research Institute research publications.

Press Releases on Seattle Biomedical Research Institute:

BioPortfolio Logo
Business, Life Sciences Leaders Launch 'We Work for Health' Economic Development and Jobs Campaign in Washington State 23rd April, 2009 We Work for Health
SEATTLE, April 23 /PRNewswire/ -- An alliance of Washington state business, academic, government and community leaders today launched "We Work for Health," a landmark statewide effort to
Life Sciences Discovery Fund Awards $4.7 Million to Support New Vaccine Program 16th December, 2008 Fred Hutchinson Cancer Research Center
SEATTLE, Dec. 16 /PRNewswire/ -- The Washington Life Sciences Discovery Fund (LSDF) has awarded nearly $4.7 million to launch the start-up phase of the Washington Vaccine Alliance (WAVA) and to

BioNews Results for Seattle Biomedical Research Institute:

Washington Global Health Alliance completes internal coordination study of global health
News-Medical.Net:  Nov 19 2009 12:02PM Matching: seattle biomedical research institute
Conjugated Equine Estrogen Influence on Mammographic Density in Postmenopausal Women in a Substudy of the Wome
Journal of Clinical Oncology:  Nov 11 2009 8:38PM Matching: seattle biomedical research institute
Seattle Biotech Needs More Bars, Less University Red Tape, and the Same Daring Attitude, & Other Highlights from Seattle Life Sciences 2029
Xconomy:  Oct 21 2009 2:13PM Matching: seattle biomedical research institute
Novo Nordisk opens Seattle research center for autoimmune diseases
Seattle Times:  Sep 18 2009 6:25PM Matching: seattle biomedical research institute

Seattle Biomedical Research Institute Patents:

US Patent No.Title
7261884 Live genetically attenuated malaria vaccine
7122179 Live genetically attenuated malaria vaccine
6627191 Anti-transforming growth factor Beta (TGF-.beta.) treated stem cell composition and method

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 90 individuals from Seattle Biomedical Research Institute using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 539 times since April 2007, the link to the organisation's website has been followed 106 times

Recent Search Terms used to find this page: biomedical startup companies in USA | Seattle Institute for the Life Sciences | jobs in biomedical research, washington state | biomedical research institute | biomedical research institute | seattle biomedical engineer | biomedical research jobs in Washington state | seattle biomedical startup | seattle biomedical | biomedicine seattle | .

Search for more companies in Seattle

Search for more companies in Washington



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Seattle Biomedical Research Institute

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.